المؤلفون: Adam, Pia, Kircher, Stefan, Sbiera, Iuliu, Koehler, Viktoria Florentine, Berg, Elke, Knösel, Thomas, Sandner, Benjamin, Fenske, Wiebke Kristin, Bläker, Hendrik, Smaxwil, Constantin, Zielke, Andreas, Sipos, Bence, Allelein, Stephanie, Schott, Matthias, Dierks, Christine, Spitzweg, Christine, Fassnacht, Martin, Kroiss, Matthias

المساهمون: German Study Group for Rare Malignant Tumors of the Thyroid and Parathyroid Glands

المصدر: Frontiers in Endocrinology

مصطلحات موضوعية: PD-L1, Adult, Male, Adolescent, tyrosine kinase inhibitor (TKI), Endocrinology, Diabetes and Metabolism, Drug Evaluation, Preclinical, Antineoplastic Agents, Antibodies, Monoclonal, Humanized, Thyroid Carcinoma, Anaplastic, tyrosine kinase inhibitor (TKI), immune checkpoint inhibitor (ICI), immunohistochemistry, immunotherapy, PD-L1, FGFR, B7-H1 Antigen, Endocrinology, Antineoplastic Agents, Immunological, Germany, Humans, RNA, Messenger, Thyroid Neoplasms, ddc:610, Original Research, Aged, Aged, 80 and over, immune checkpoint inhibitor (ICI), FGFR, Phenylurea Compounds, Middle Aged, Receptors, Fibroblast Growth Factor, immunohistochemistry, Quinolines, Female, immunotherapy

وصف الملف: application/pdf; application/octet-stream

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::a8a72226703b5be701a08e0e6740e8b2